This is a non-core endpoint: only basic statistics are computed.
Burkitt lymphoma (controls excluding all cancers)
C3_BURKITT_EXALLC
No definition available.
Endpoint definition
↥individuals
Apply sex-specific rule None
Check conditions
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Remove individuals based on genotype QC
18
Control definitions
Extra metadata
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
Burkitt lymphoma (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Burkitt lymphoma
- Burkitt lymphoma
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms (controls excluding all cancers)
- Any event in cancer register
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 18 | 7 | 11 |
Unadjusted prevalence (%) | 0.00 | 0.00 | 0.01 |
Mean age at first event (years) | 43.72 | 37.06 | 47.95 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_BURKITT_EXALLC – Burkitt lymphoma (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Burkitt lymphoma (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.